Novo Nordisk's Wegovy Pill Launch Attracts New Patients to GLP-1 Weight Loss Treatment

Novo Nordisk's new Wegovy pill has seen an explosive launch, drawing a new wave of patients into GLP-1 weight loss treatments. CNBC interviewed five U.S. patients who shared their varying initial experiences with the drug following its introduction.